Policy | May 09, 2026
NIPER, Raebareli signs technology transfer pact with Lofty Laboratories
Academia-industry partnership to promote indigenous technology commercialization in biotech sector
Academia-industry partnership to promote indigenous technology commercialization in biotech sector
The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy
Former DCGI and now advisor to UP CM highlights medical device growth, healthcare expansion, and investment opportunities in the state
The agreement targets a long-standing technical hurdle in the field: maintaining chemical purity as RNA constructs extend beyond 100 nucleotides
The event will bring together industrial leaders, technology providers, and policymakers to discuss real-world Industrial AI applications in Bangalore
Successful inspection outcome strengthens company’s regulatory compliance and manufacturing standards in China
LIR Life is working on a patch-based, transdermal delivery system for GLP-1 therapies targeting obesity
The investment will upgrade and expand production capabilities at Lilly Lebanon API and Lilly Lebanon Advanced Therapies
The company reported robust revenue and profit growth for FY26, supported by strong CDMO performance, improving margins, and expansion across advanced manufacturing platforms
The US FDA completed a pre-license inspection of Biocon Biologics’ biosimilars manufacturing site at Biocon Park between April 20 and April 29, 2026
Subscribe To Our Newsletter & Stay Updated
